Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Autoimmune hepatitis]

O Marcais1, D Larrey

  • 1Service d'hépato-gastro-entérologie, hôpital Saint-Eloi, Montpellier.

La Revue Du Praticien
|January 1, 1994
PubMed
Summary
This summary is machine-generated.

Autoimmune hepatitis is an uncommon liver disease primarily affecting young women. Treatment with corticosteroids and azathioprine can manage the condition, but liver transplantation may be necessary for severe cases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The negative impact of HBV/HCV coinfection on cirrhosis and its consequences.

Alimentary pharmacology & therapeutics·2017
Same author

MACVIA-LR (Fighting Chronic Diseases for Active and Healthy Ageing in Languedoc-Roussillon): A Success Story of the European Innovation Partnership on Active and Healthy Ageing.

The Journal of frailty & aging·2016
Same author

The CUPIC algorithm: an accurate model for the prediction of sustained viral response under telaprevir or boceprevir triple therapy in cirrhotic patients.

Journal of viral hepatitis·2015
Same author

Tacrolimus and the risk of solid cancers after liver transplant: a dose effect relationship.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2015
Same author

Case definition and phenotype standardization in drug-induced liver injury.

Clinical pharmacology and therapeutics·2011
Same author

[Anicteric cholestasis revealing schistosomiasis at a distance from the infection site].

Medecine tropicale : revue du Corps de sante colonial·2011
Same journal

[Prolonged fever].

La Revue du praticien·2026
Same journal

[Lower gastrointestinal bleeding].

La Revue du praticien·2026
Same journal

[Management of antiplatelet agents and oral anticoagulants in cases of gastrointestinal bleeding].

La Revue du praticien·2026
Same journal

[A history of child abuse intervention in the West].

La Revue du praticien·2026
Same journal

[Agranulocytose médicamenteuse].

La Revue du praticien·2026
Same journal

[Patient education in heart failure].

La Revue du praticien·2026
See all related articles

Area of Science:

  • Hepatology
  • Immunology
  • Internal Medicine

Background:

  • Autoimmune hepatitis (AIH) is a rare inflammatory liver condition.
  • It predominantly affects young women and is linked to hypergammaglobulinemia and autoantibodies.
  • AIH has distinct subtypes: Type 1 (anti-smooth muscle/anti-nuclear antibodies), Type 2 (anti-LKM1 antibodies), and Type 3 (anti-SLA antibodies).

Purpose of the Study:

  • To provide a comprehensive overview of autoimmune hepatitis.
  • To discuss the classification, associations, and clinical course of AIH.
  • To outline current treatment strategies and prognosis for AIH patients.

Main Methods:

  • Review of existing literature on autoimmune hepatitis.
  • Analysis of clinical characteristics, serological markers, and genetic associations (e.g., HLA types).

Related Experiment Videos

  • Evaluation of treatment outcomes with corticosteroids and immunosuppressive agents.

    • Main Results:

    • AIH is associated with specific autoantibodies and HLA types (HLA A1 B8 DR3, HLA DR4).
    • Untreated AIH can progress to cirrhosis or fulminant hepatitis.
    • Corticosteroids are effective but relapses are common after withdrawal; azathioprine aids in maintaining remission and reducing steroid dosage.

    Conclusions:

    • Autoimmune hepatitis requires prompt diagnosis and management.
    • Combination therapy with corticosteroids and azathioprine improves long-term outcomes.
    • Liver transplantation remains an option for end-stage liver disease or fulminant hepatic failure.